| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0018600 | Exon-Exon | chr10:31749966-31813041 | chr10:31461037-31524113 | 187 nt | 0.3583 |
| hsa_ZEB1_0018000 | Exon-Exon | chr10:31749966-31816045 | chr10:31461037-31527117 | 250 nt | 0.3120 |
| hsa_ZEB1_0018800 | Exon-Exon | chr10:31749990-31803636 | chr10:31461061-31514708 | 112 nt | 0.3750 |
| hsa_ZEB1_0018700 | Exon-Exon | chr10:31749990-31813041 | chr10:31461061-31524113 | 2703 nt | 0.4262 |
| hsa_ZEB1_0018900 | Exon-Exon | chr10:31750041-31784767 | chr10:31461112-31495838 | 189 nt | 0.5132 |
| hsa_chr10_0276200 | Intergenic-Intergenic | chr10:31750088-31791383 | chr10:31461159-31502455 | 79 nt | 0.5190 |
| hsa_ZEB1_0019000 | Exon-Exon | chr10:31750120-31784761 | chr10:31461191-31495832 | 104 nt | 0.5192 |
| hsa_ZEB1_0019100 | Exon-Exon | chr10:31750126-31784767 | chr10:31461197-31495838 | 104 nt | 0.5096 |
| hsa_ZEB1_0019200 | Intron-Intron | chr10:31751745-31752135 | chr10:31462816-31463206 | 391 nt | 0.3836 |
| hsa_ZEB1_0019300 | Intron-Intron | chr10:31755446-31755658 | chr10:31466517-31466729 | 213 nt | 0.2817 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].